Jefferies Boosts PT on Celldex Therapeutics (CLDX) to $15
Tweet Send to a Friend
Jefferies raised its price target on Buy-rated Celldex Therapeutics (NASDAQ: CLDX) from $9 to $15.
The firm comments, "CLDX ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
The firm comments, "CLDX ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
